(Q33589159)

28 July 2017

1 reference

title

New acellular pertussis-containing paediatric combined vaccines (English)

1 reference

28 July 2017

Pines E

1

1 reference

28 July 2017

Barrand M

2

1 reference

28 July 2017

Fabre P

3

1 reference

28 July 2017

Salomon H

4

1 reference

28 July 2017

Blondeau C

5

1 reference

28 July 2017

Wood SC

6

1 reference

28 July 2017

Hoffenbach A

7

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 March 1999

1 reference

28 July 2017

1 reference

28 July 2017

volume

17

1 reference

28 July 2017

issue

13-14

1 reference

28 July 2017

page(s)

1650-1656

1 reference

Combination vaccines: hopes and challenges

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900422-8

7 January 2021

Issues in design of clinical trials of combination vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900422-8

7 January 2021

Combination vaccines consisting of acellular pertussis vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900422-8

7 January 2021

Potential alterations in immunogenicity by combining or simultaneously administering vaccine components.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900422-8

7 January 2021

Reduced response to multiple vaccines sharing common protein epitopes that are administered simultaneously to infants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900422-8

7 January 2021

Combined immunization against diphtheria, tetanus, and pertussis in children over three months of age; including an evaluation of the effectiveness of two immunizing agents

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900422-8

7 January 2021

Pertussis in Sweden after the cessation of general immunization in 1979.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900422-8

7 January 2021

The acellular pertussis vaccine trials: an interpretation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900422-8

7 January 2021

Clinical experience of a tricomponent acellular pertussis vaccine combined with diphtheria and tetanus toxoids for primary vaccination in 22,505 infants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900422-8

7 January 2021

Safety and immunogenicity of two acellular pertussis vaccines with different pertussis toxoid and filamentous hemagglutinin content in infants 2-6 months old.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900422-8

7 January 2021

A randomized double-blind trial comparing a two-component acellular to a whole-cell pertussis vaccine in Senegal

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900422-8

7 January 2021

Will US polio immunization rely on IPV or OPV?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900422-8

7 January 2021

Comparative evaluation of immunization with live attenuated and inactivated poliovirus vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900422-8

7 January 2021

Efficacy and safety of a Haemophilus influenzae type b capsular polysaccharide-tetanus protein conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900422-8

7 January 2021

The impact of Haemophilus influenzae type b vaccination in Sweden.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900422-8

7 January 2021

Experience in Finland with Haemophilus influenzae type b vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900422-8

7 January 2021

Immunogenicity and safety of a liquid combination of DTP-PRP-T [corrected] vs lyophilized PRP-T reconstituted with DTP

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900422-8

7 January 2021

Safety and immunogenicity of a combined pentavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus and Haemophilus influenzae type b-tetanus conjugate vaccine in infants, compared with a whole cell pertussis pentavalent vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900422-8

7 January 2021

[Trial of prevention of severe Haemophilus influenzae type b infections and trial of tolerance, after PRP-T vaccination, in the Val-de-Marne region]

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900422-8

7 January 2021

Clinical acceptability and immunogenicity of a pentavalent parenteral combination vaccine containing diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis and Haemophilus influenzae type b conjugate antigens in two-, four- and six-mont

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900422-8

7 January 2021

Randomised trial of the effect of co-administration with acellular pertussis DTP vaccine on immunogenicity of Haemophilus influenzae type b conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900422-8

7 January 2021

Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900422-8

7 January 2021

Pneumococcal disease: prospects for a new generation of vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900422-8

7 January 2021

A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900422-8

7 January 2021

10.1016/S0264-410X(98)00422-8

Identifiers

DOI

1 reference

28 July 2017

1 reference